Finance

Lists
Why is SNOA down 10,83%?
Dive Deeper
SNOA:NASDAQ
Sonoma Pharmaceuticals Inc
USD 0,72
-10,83%
(-0,088) 1D
20 Nov., 16:00:00 GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SNOA...
Open
USD 0,82
High
USD 0,84
Low
USD 0,72
Mkt. cap
3,65 m.
Avg. vol.
71,54 k
Volume
103,74 k
52-wk high
USD 3,95
52-wk low
USD 0,72
EPS
-USD 0,91
Beta
1,31
Shares outstanding
5,06 m.
No. of employees
260
Open
USD 0,82
High
USD 0,84
Low
USD 0,72
Mkt. cap
3,65 m.
Avg. vol.
71,54 k
Volume
103,74 k
52-wk high
USD 3,95
52-wk low
USD 0,72
EPS
-USD 0,91
Beta
1,31
Shares outstanding
5,06 m.
No. of employees
260
News stories
From web sources and news partners
About Sonoma Pharmaceuticals Inc
CEO-
Employees260
Founded1999
HeadquartersBoulder, Colorado, Verenigde State van Amerika
SectorHealth Care
IndustryPharmaceutical industry
Analyst
Recommendation
Action
Price target
Projected
Date
No analyst ratings found.
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Des. 2025
Mrt. 2026
Jun. 2026
Sep. 2026
Revenue
4,35 m.
5,56 m.
6,41 m.
7,17 m.
Cost of goods sold
2,70 m.
3,38 m.
3,83 m.
4,37 m.
Cost of revenue
2,70 m.
3,38 m.
3,83 m.
4,37 m.
Research and development expenses
557,00 k
545,00 k
597,00 k
469,00 k
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,77 m.
1,99 m.
2,02 m.
2,05 m.
Operating expense
2,33 m.
2,53 m.
2,62 m.
2,52 m.
Total operating expenses
5,03 m.
5,91 m.
6,45 m.
6,88 m.
Operating income
-678,00 k
-351,00 k
-40,00 k
290,00 k
Other non operating income
-271,00 k
-1,59 m.
-
-
EBT including unusual items
-949,00 k
-497,00 k
-330,00 k
382,00 k
EBT excluding unusual items
-949,00 k
-497,00 k
-330,00 k
382,00 k
Income tax expense
-130,00 k
84,00 k
-
448,00 k
Effective tax rate
13,70%
-16,90%
-
117,28%
Other operating expenses
-
-
-
-
Net income
-819,00 k
-581,00 k
-330,00 k
-66,00 k
Net profit margin
-18,83%
-10,45%
-5,15%
-0,92%
Earnings per share
-0,48
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-
Net interest expenses
-
-
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-644,00 k
-318,00 k
-8,00 k
320,00 k
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google-programme